BioCentury
ARTICLE | Financial News

Amgen ebbs after rumor-related bump

July 19, 2001 7:00 AM UTC

AMGN was off $0.56 to $59.49 on Thursday. On Wednesday, the company added $4.99 to $60.05 on 15 million shares, as rumors circulated that the company had received FDA approval for its Aranesp darbepoi...